Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C J Wraight

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Pharmacology & Therapeutics|July 13, 2001
Antisense oligonucleotides in cutaneous therapyC J Wraight, P J White
The Journal of Investigative Dermatology|October 1, 1995
Insulin-like growth factor-I and epidermal growth factor regulate insulin-like growth factor binding protein-3 (IGFBP-3) in the human keratinocyte cell line HaCaTC J Wraight, G A Werther
Methods in Enzymology|January 1, 1986
The effect of pristane on ascites tumor formation and monoclonal antibody productionN J Hoogenraad, C J Wraight
Expert Opinion on Biological Therapy|December 19, 2003
Antisense oligonucleotide treatments for psoriasisP J White, L M Atley, C J Wraight
The Journal of Investigative Dermatology|April 5, 2001
Calcium regulates the expression of insulin-like growth factor binding protein-3 by the human keratinocyte cell line HaCaTS R Edmondson, G A Werther, C J Wraight
The Journal of Investigative Dermatology|November 1, 1994
A keratinocyte cell line synthesizes a predominant insulin-like growth factor-binding protein (IGFBP-3) that modulates insulin-like growth factor-I actionC J Wraight, M M Murashita, V C Russo, et al.
Antisense & Nucleic Acid Drug Development|July 25, 2000
Antisense inhibition of IGF receptor expression in HaCaT keratinocytes: a model for antisense strategies in keratinocytesP J White, R D Fogarty, G A Werther, et al.
The Journal of Investigative Dermatology|April 1, 1997
Expression of insulin-like growth factor binding protein-3 (IGFBP-3) in the psoriatic lesionC J Wraight, S R Edmondson, D W Fortune, et al.
The Journal of Clinical Endocrinology and Metabolism|May 14, 1999
Interactions between growth hormone, insulin-like growth factor I, and basic fibroblast growth factor in melanocyte growthS R Edmondson, V C Russo, A C McFarlane, et al.
Journal of Cellular Physiology|April 13, 1999
Expression of insulin-like growth factor binding protein-3 (IGFBP-3) in human keratinocytes is regulated by EGF and TGFbeta1S R Edmondson, M M Murashita, V C Russo, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Pharmacology & Therapeutics|July 13, 2001
Antisense oligonucleotides in cutaneous therapyC J Wraight, P J White
The Journal of Investigative Dermatology|October 1, 1995
Insulin-like growth factor-I and epidermal growth factor regulate insulin-like growth factor binding protein-3 (IGFBP-3) in the human keratinocyte cell line HaCaTC J Wraight, G A Werther
Methods in Enzymology|January 1, 1986
The effect of pristane on ascites tumor formation and monoclonal antibody productionN J Hoogenraad, C J Wraight
Expert Opinion on Biological Therapy|December 19, 2003
Antisense oligonucleotide treatments for psoriasisP J White, L M Atley, C J Wraight
The Journal of Investigative Dermatology|April 5, 2001
Calcium regulates the expression of insulin-like growth factor binding protein-3 by the human keratinocyte cell line HaCaTS R Edmondson, G A Werther, C J Wraight
The Journal of Investigative Dermatology|November 1, 1994
A keratinocyte cell line synthesizes a predominant insulin-like growth factor-binding protein (IGFBP-3) that modulates insulin-like growth factor-I actionC J Wraight, M M Murashita, V C Russo, et al.
Antisense & Nucleic Acid Drug Development|July 25, 2000
Antisense inhibition of IGF receptor expression in HaCaT keratinocytes: a model for antisense strategies in keratinocytesP J White, R D Fogarty, G A Werther, et al.
The Journal of Investigative Dermatology|April 1, 1997
Expression of insulin-like growth factor binding protein-3 (IGFBP-3) in the psoriatic lesionC J Wraight, S R Edmondson, D W Fortune, et al.
The Journal of Clinical Endocrinology and Metabolism|May 14, 1999
Interactions between growth hormone, insulin-like growth factor I, and basic fibroblast growth factor in melanocyte growthS R Edmondson, V C Russo, A C McFarlane, et al.
Journal of Cellular Physiology|April 13, 1999
Expression of insulin-like growth factor binding protein-3 (IGFBP-3) in human keratinocytes is regulated by EGF and TGFbeta1S R Edmondson, M M Murashita, V C Russo, et al.
Pageof 2